Tags : Neo Kuma Ventures

Female Led

Monument Therapeutics secures £2.625 million Seed investment led by Catapult

Digital brain biomarker company Monument Therapeutics raises £2.6 million Cambridge Cognition spin-out targets schizophrenia and post-operative cognitive dysfunction  Manchester, UK, August 2021: Monument Therapeutics, a stratified medicine company, has raised £2.625 million in seed funding to spin out of Cambridge Cognition Ltd and relocate to Alderley Park, Cheshire. The new company will focus on applying […]Read More